Invega Sustenna 150mg Injection

Invega sustenna 150mg injection contains an active component as Paliperidone. It is an antipsychotic medication for schizophrenia and related mental disorders like schizoaffective disorder. It belongs to a class of drugs known as atypical antipsychotics. This medication works by affecting certain neurotransmitters in the brain, specifically dopamine and serotonin, which regulate mood, behavior, and cognition. Schizophrenia is a chronic mental disorder characterized by delusions (false beliefs), hallucinations (false perceptions), disorganized thinking, disorganized or catatonic behavior, and negative symptoms such as reduced emotional expression or motivation. Schizoaffective disorder is a condition that combines symptoms of schizophrenia with mood disturbances, such as depression or mania. Individuals with schizoaffective disorder experience a combination of psychotic symptoms and mood episodes.

If you have a known allergy to Invega sustenna 150mg injection or other antipsychotic medications, you should inform your healthcare provider before starting treatment. This medication is contraindicated (not recommended) in individuals with known hypersensitivity or allergy to this medication or any of its components. It should not be used in patients who have experienced severe hypersensitivity reactions to other antipsychotic medications from the same class. Additionally, it should be used cautiously in patients with a history of cardiovascular disease, seizures, or certain medical conditions. It's important to discuss your complete medical history with your healthcare provider before starting this medication or any other medication. Dosage adjustments may be necessary in patients with renal impairment. The specific age at which Invega sustenna 150mg injection may be considered for pediatric use can vary based on regulatory approvals and clinical guidelines in different countries.